-
Study aim
-
Determining the Effectiveness of Unified Transdiagnostic Interventions on Experiential Avoidance, Emotion Regulation, and Treatment Sustainability in Individuals Undergoing Substance Abuse Treatment
-
Design
-
A randomized, controlled, parallel-group clinical trial will be conducted on 30 individuals undergoing substance abuse treatment. Participants will be randomly assigned to either the intervention group or the control group using a simple randomization method.
-
Settings and conduct
-
This study is being conducted at the Sina Substance Abuse Treatment Center in Semnan, involving individuals undergoing treatment for substance abuse who, following an initial assessment, are randomly assigned to either an intervention group or a control group.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: age 18–60 years, diagnosis of substance use disorder, at least one month of maintenance treatment, and informed consent. Exclusion criteria: severe psychiatric or cognitive disorders, need for hospitalization or urgent psychiatric services, and concurrent use of substances or medications affecting cognitive and emotional states.
-
Intervention groups
-
In this study, the intervention group undergoes an integrated transdiagnostic intervention delivered in eight weekly, 90-minute sessions. The session content encompasses increasing awareness of emotional experiences, identifying maladaptive emotional and behavioral patterns, teaching emotion regulation skills, fostering acceptance of and exposure to emotions, and reducing experiential avoidance. The control group does not receive the specialized intervention and continues to receive their usual therapeutic services throughout the study.
-
Main outcome variables
-
Experiential avoidance, emotion regulation, and treatment durability.